SRF617
SRF617-201
Phase 2 small_molecule terminated
Quick answer
SRF617 for Metastatic Castration-resistant Prostate Cancer is a Phase 2 program (small_molecule) at Arcus Biosciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Arcus Biosciences
- Indication
- Metastatic Castration-resistant Prostate Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated